CRISPR companies and licensing agreements. Bold lines represent non-exclusive licensing. Dashed lines represent exclusive licensing. In the middle, the four most important owners of CRISPR patents. In dark blue, companies applying CRISPR for health-related applications. In green, companies applying CRISPR in the crop industry and biotech industry. In black, companies developing tools, cell lines and animal models